Lotus Ventures Inc.

J

CA54571Q1081

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 12:37:16 2024-03-28 pm EDT			5-day change	1st Jan Change
0.01 ^CAD	-.--%		-.--%	-33.33%

2023	Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	CI
2023	Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	CI

Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2022

August 01, 2022

Lotus Ventures Inc. reported earnings results for the nine months ended May 31, 2022. For the nine months, the company reported sales was CAD 1.24 million compared to CAD 4.25 million a year ago. Net income was CAD 0.137848 million compared to CAD 0.198471 million a year ago.

Latest news about Lotus Ventures Inc.

Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	Dec. 15	CI
Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	23-08-02	CI
Lotus Ventures Inc. Reports Earnings Results for the Half Year Ended February 28, 2023	23-04-30	CI
Lotus Launches Keylime Kush Flower in Ontario Under the Lotus Cannabis Co. Brand	23-04-11	CI
Lotus Ventures Inc. Shares Update on Keylime Kush Sales in British Columbia	23-03-10	MT
Lotus Ventures Inc. Updates on Its Initial Sales Results from the Launch of Its Keylime Kush Flower and Pre-Rolls in British Columbia	23-03-10	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-02-28	CI
Lotus Ventures Inc. Auditor Raises 'Going Concern' Doubt	23-02-21	CI
Lotus Ventures Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	23-02-21	CI
Lotus Launches First Keylime Kush Cultivar Under the Lotus Cannabis Co. Brand in British Columbia	23-01-23	CI
Lotus Ventures Inc. Appoints Albert Duwyn as New Chairman of the Board of Directors	22-10-06	CI
Earnings Flash (LTTSF) LOTUS VENTURES Posts Q3 EPS $0.00	22-08-02	MT
Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2022	22-08-01	CI
Lotus Ventures Inc. Reports Earnings Results for the Half Year Ended February 28, 2022	22-04-29	CI
Lotus Ventures Inc. Announces Second Official Collaborative Strain Launch with Auxly Cannabis Group Inc	22-04-20	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	22-01-30	CI
Lotus Ventures Inc. Auditor Raises 'Going Concern' Doubt	21-12-28	CI
Lotus Ventures Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	21-12-28	CI
Lotus Ventures Inc. Accelerates Path to Retail Market Sales Upon Receipt of Standard Processing Licence from Health Canada	21-09-08	CI
Lotus Ventures Inc. Provides Earnings Guidance for the Fifth Quarter of 2022 and Fourth Quarter Ended August 2021	21-09-08	CI
Lotus Ventures Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	21-07-30	CI
Lotus Ventures Inc. Reports Earnings Results for the Second Quarter Ended February 28, 2021	21-04-29	CI
Lotus Ventures Inc. Announces Changes to Its Board	21-02-16	CI
Lotus Ventures Inc. Reports Revenue Results for the First Quarter Ended January 31, 2021	21-02-01	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2020	21-01-29	CI

Chart Lotus Ventures Inc.

Duration

Period

More charts

Company Profile

Lotus Ventures Inc. is a Canada-based licensed cannabis producer and owner of the Lotus Cannabis Co. brand. The Company primarily cultivates cannabis flowers, which are sold in the wholesale, recreational, and medical markets across Canada. The Company owns and operates a 22,500 square foot indoor cannabis production facility in Armstrong, British Columbia and holds the licenses for cultivation and sale of cannabis in Canada. It has grown several cultivars, including the Keylime Kush, Black Blossom, Tranquil Elephantizer, and Kalifornia. Its Keylime Kush recreational portfolio includes 3.5 gram flower, 14 gram flower, and 3 x 0.5 gram pre-rolls. The Company sells its flagship product, the Keylime Kush, to over 300 retail stores across British Columbia and Ontario.

Sector

Pharmaceuticals

Calendar

2024-07-30 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
LOTUS VENTURES INC.	-33.33%	841K
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B